As ROS, hypoxia, inflammation, and ER stress are associated with cancer initiation and progression [46,47], it is plausible that these stresses contribute to the increased expression of SESN2 in endometrial cancer tissues. The gene discussed is SESN2; the disease is endometrial cancer.